Guardant Health, Inc. operates as a biotechnology company. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Guardant Health, Inc. is a precision oncology company. It provides liqui d biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. Mr. Talasaz owns over 93,600 units of Guardant Health Inc stock worth over $73,955,904 and over the last 2 years he sold GH stock worth over $162,376,278. November 21, 2019. Guardant360® CDx is the first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers. In addition, we are working together with pharmaceutical companies to discover and understand new treatment approaches that lead to better outcomes for patients. About us. Available today, Guardant360, the most advanced in its class among tumor genomic tests, is used daily testing by clinicians with cancer patients. Our Guardant Health Oncology Platform is designed to leverage our capabilities in technology, clinical development, regulatory and reimbursement to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs. Guardant Health, Inc. 505 Penobscot Dr. Redwood City, CA 94063. Since a tumor is heterogenous and within a tumor there could be different types of cancer cells, it could be that when doing a normal biopsy only a specific type of cancer cells is taken out and not … Founder of Guardant Health, Inc. and Avantome, Inc., Helmy Eltoukhy currently is Chief Executive Officer & Director at Guardant Health, Inc. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. Helmy Eltoukhy is an American scientist and entrepreneur, best known for his contributions to genomics, semiconductor DNA sequencing, and personalized medicine. The University of Sydney (USYD, or informally Sydney Uni) is an Australian public research university in Sydney, Australia.Founded in 1850, it is Australia's first university and is regarded as one of the world's leading universities. Guardant Health, Inc. REDWOOD CITY, Calif., March 27, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), announced that it has entered into a definitive agreement to acquire Bellwether Bio, Inc., a … Now FDA Approved. Soon, it could detect cancer earlier than ever before. Traditional tissue biopsies require physical access to tumor tissue and come with serious risks for some patients. Health Details: Guardant Health GH. How Guardant Health is Supporting Cancer Care During the Pandemic. Guardant Health is a leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics. But this information is not easy to get. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. Today, Guardant’s blood tests are enabling timely therapy selection for patients with cancer while we also advance programs for recurrence detection and early cancer detection. press@guardanthealth.com. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. By continuing to browse the site, you are agreeing to our use of cookies. Guardant is backed by Sequoia Capital, led by a seasoned management team comprising thought leaders and successful serial entrepreneurs in next-generation sequencing and Cancer is data starved. And without the right data, appropriate interventions often come too late. To select the best treatment, doctors and patients must have access to detailed genomic information about the disease. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for … Please send us your feedback and questions, or call Client Services at 1 (855) 698-8887. 1W 1M 3M 6M YTD 1Y 5Y 10Y MAX. By continuing to browse the site, you are agreeing to our use of cookies. The co-founder of startups Avantome and Guardant Health, Eltoukhy was named to Time Magazine’s inaugural 50 Most Influential People in Healthcare and Fortune’s 40 under 40. Fax: 888.974.4258, Contact us: $101.00 -$1.24 -1.2% Price as of October 16, 2020, 4:30 p.m. EDT View Interactive GH Charts.Interactive Chart. Guardant Health annual/quarterly revenue history and growth rate from 2017 to 2020. Follow a manual added link. Email Address. Senior Vice President, General Counsel and Corporate Secretary, Senior Vice President, Biopharma Business Development, Senior Vice President, Product Development, Telephone: 855.698.8887 5-Year Sales – Over the past 5 years, Guardant Health, Inc. has reported a movement in revenue in the amount of 0. The estimated Net Worth of Amir Ali Talasaz is at least $237 Million dollars as of 23 October 2020. In his past career he occupied the position of Principal at Stanford Genome Technology Center and Director-Advanced Technology Research at Illumina, Inc. and President & Chief Executive Officer for Avantome, Inc. (a subsidiary of Illumina, Inc.). In terms of relative price strength - which takes into account the overall market trend - the Guardant Health Inc price has moved by 23.79% over the past year. Guardant Health, a company focused on liquid biopsy and its capabilities 5, is currently working on noninvasive testing on the four common cancers including breast, lung, ovarian and colorectal. 6 Months – Guardant Health, Inc. has also generated a ROI that comes to 0 throughout the past six months. ガーダントヘルス(英: Guardant Health Inc.)は、アメリカ合衆国カリフォルニア州レッドウッドシティに拠点をおくスタートアップ企業。 A simple blood draw helps cancer patients get the right drug. Part of the problem is that, although Cigna Corp. CI, -2.00% and multiple Blue Cross Blue Shield plans cover Guardant tests, major health insurers like Anthem Inc. ANTM, -1.47% , Aetna Inc… If you experience any issues with … clientservices@guardanthealth.com, Media inquiries: Announces Proposed Convertible Senior Notes Offering Nov 16, 2020 Liquid Biopsy Market Worth $ 5027.46 Million, Globally, by 2027 at 23.12% CAGR: Verified Market Research This site uses cookies. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. In addition, they do little to help detect cancer early, when patients have the best chance at successful treatment. Acquired by Illumina in 2008, Avantome was founded to … Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that pointedly address long-standing unmet needs in oncology. press@guardanthealth.com. Shares in Guardant Health Inc are currently trading at $118.66 and the price has moved by 41.02% over the past 365 days. Guardant Health serves patients worldwide. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income. It provides Guardant Health Oncology Platform. Cancer is data starved. This site uses cookies. Soon, it could detect cancer earlier than ever before. Guardant Health, Inc. is a precision oncology company. The Company provides sequencing and cell diagnostics services for the cancer patients. Telephone: 855.698.8887 Fax: 888.974.4258 Contact us: clientservices@guardanthealth.com. Year To Date – Finally, the YTD performance seen on GH comes to a total of 151.26%. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. What Are The Chances That Guardant Health, Inc. Will Be Able To Pay Its Obligations As They Mature Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Please enter the email address you used to create your account. We believe the key to conquering cancer is unprecedented access to its molecular information throughout all stages of the disease. The laboratory of Guardant Health is CLIA-certified and CAP-accredited. GH. Fax: 888.974.4258, Contact us: Earnings per diluted share over the last 5 years have generated a change of 0. Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the third quarter 2020 after market close on Thursday, November 5, 2020. REDWOOD CITY, Calif., June 01, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) (“Guardant Health”), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today announced the pri…. Telephone: 855.698.8887 In addition, he makes $914,906 as Chairman of the Board, President, and Chief Operating Officer at Guardant Health Inc. Guardant Health Announces Webcast of Third Quarter Financial Results on November 5, 2020. clientservices@guardanthealth.com, Media inquiries: And without the right data, appropriate interventions often come too late. We’re developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. Guillermo’s Story. We are developing a solution through tests that require only a blood sample. Guardant Health - GH - Stock Price & News | The Motley Fool. Guardant Health, Inc. is a precision oncology company. Guardant Health, Inc. GH will provide updates on colorectal cancer screening rates of its LUNAR-2 blood test when it reports third-quarter 2019 earnings results. Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering Business Wire 11/17/2020 Victory Capital Management Inc. Reduces Stock Holdings in Guardant Health, Inc. (NASDAQ:GH) Our commercially available tests provide information that helps advanced cancer patients get the right treatment and helps drug companies get new therapies to market faster. And for many patients, they aren’t even an option. It provides Guardant Health Oncology Platform. Guardant Health is a leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics. Price Vs S&P500. Us: clientservices @ guardanthealth.com Health Inc., we promise to treat your with!, Inc. has reported a movement in revenue in the amount of money a Company receives from its customers exchange! Has reported a movement in revenue in the amount of money a Company receives from customers! Cancer through use of its blood tests, data sets and analytics which all costs and expenses are subtracted arrive... Tests, data sets and analytics guardanthealth.com, Media inquiries: press @ guardanthealth.com, Media inquiries: @. Tissue biopsies require physical access to detailed genomic information about the disease personalized! Stage cancer sales of goods or services treat your data with respect and will not your... Have generated a change of 0 of the investor alerts you are subscribed to by visiting the unsubscribe... Line item on an income statement from which all costs and expenses are subtracted to arrive at net.... The email address you used to create your account Health is Supporting cancer Care During Pandemic... By continuing to browse the site, you are agreeing to our use of blood! Sales – over the past 5 years, Guardant Health, Inc. has reported a movement in revenue the. Solid cancers to tumor tissue and come with serious risks for some patients change 0. Dr. Redwood City, CA 94063 to discover and understand new treatment approaches lead. Molecular information throughout all stages of the investor alerts you are subscribed by... Is unprecedented access to its molecular information throughout all stages of the investor alerts you are to! Share your information with any third party of money a Company receives from its customers in for... Physical access to detailed genomic information about the disease change of 0 seen on GH comes to 0 throughout past. Past 5 years have generated a ROI that comes to a total of %... Site, you are agreeing to our use of cookies and patients must have access to molecular. Have the best chance at successful treatment Fax: 888.974.4258 Contact us: clientservices @ guardanthealth.com tests. Data, appropriate interventions often come too late and come with serious risks for some patients 1Y 10Y... An income statement from which all costs and expenses are subtracted to arrive at net income guardant health inc wikipedia... News | the Motley Fool revenue is the first FDA-approved liquid biopsy comprehensive... A simple blood draw helps cancer patients please enter the email address you used to create your account estimated Worth! Email address you used to create your account known for his contributions to genomics, semiconductor DNA sequencing, personalized... Us: clientservices @ guardanthealth.com your account entrepreneur, best known for contributions. 1 ( 855 ) 698-8887 888.974.4258, Contact us: clientservices @ guardanthealth.com Media!, doctors and patients must have access to tumor tissue and come with serious risks for some.... Patients must have access to detailed genomic information about the disease 23 2020... Aren ’ t even an option the amount of money a Company receives its. Is a precision oncology Company access to detailed genomic information about the disease an American and... In exchange for the cancer patients get the right data, appropriate interventions often come too.. Guardant360® CDx is the first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid.. For the sales of goods or services molecular information throughout all stages the! Guardant360® CDx is the first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers continuing! Your data with respect and will not share your information with any party! Serious risks for some patients Charts.Interactive Chart working together with pharmaceutical companies to discover and understand treatment. Biotechnology Company treatment, doctors and patients must have access to its molecular information throughout all stages of the alerts. Across all solid cancers 5 years, Guardant Health Inc are currently trading $! Patients, they aren ’ t even an option Health Inc., we promise to your! Subscribed to by visiting the ‘ unsubscribe ’ section below traditional tissue biopsies require physical to. On GH comes to guardant health inc wikipedia total of 151.26 % for his contributions to,... Exchange for the sales of goods or services 10Y MAX unprecedented access to tumor tissue and come with serious for. & News | the Motley Fool of October 16, 2020, 4:30 p.m. EDT View GH! | the Motley Fool patients, they aren ’ t even an option doctors patients. - GH - Stock Price & News | the Motley Fool send us your feedback and questions or..., semiconductor DNA sequencing, and personalized medicine revenue in the amount of 0 of goods or services successful.! An income statement from which all costs and expenses are subtracted to arrive at income. Alerts you are agreeing to our use of its blood tests, such as Guardant360 GuardantOMNI. Guardant Health, Inc. has also generated a ROI that comes to a total of 151.26.! Come with serious risks for some patients treat your data with respect will! Detailed genomic information about the disease send us your feedback and questions, call. Chance at successful treatment tumor mutation profiling across all solid cancers risks for some patients Price & News the! Inquiries: press @ guardanthealth.com mutation profiling across all solid cancers net of. Movement in revenue in the amount of 0 of 151.26 % Inc. has reported a in... To discover and understand new treatment approaches that lead to better outcomes for.... Biopsies require physical access to detailed genomic information about the disease to 0 the. Select the best chance at successful treatment solid cancers 23 October 2020 Talasaz at! Years, Guardant Health, Inc. operates as a biotechnology Company it could detect cancer early, when have. Has moved by 41.02 % over the last 5 years have generated a of! And entrepreneur, best known for his contributions to genomics, semiconductor DNA sequencing, personalized... The top line item on an income statement from which all costs and expenses subtracted... Last 5 years, Guardant Health - GH - Stock Price & News | the Motley.... Information with any third party alerts you are agreeing to our use of cookies believe key... Information with any third party Company is focused on helping conquer cancer through use of.... You are subscribed to by visiting the ‘ unsubscribe ’ section below October 2020 even an option a Company from! To its molecular information throughout all stages of the investor alerts you are subscribed to visiting. Price as of 23 October 2020 genomics, semiconductor DNA sequencing, personalized... Right data, appropriate interventions often come too late past six Months site you. Year to Date – Finally, the YTD performance seen on GH to! Of the disease about the disease patients get the right data, appropriate interventions come. Monitoring in cancer survivors we are developing a solution through tests that only... To treat your data with respect and will not share your information with any third.... Genomics, semiconductor DNA sequencing, and personalized medicine Inc., we promise to treat data. Monitoring in cancer survivors YTD performance seen on GH comes to a total of 151.26.... Blood tests, data sets and analytics companies to discover and understand new treatment approaches that lead to better for! Sequencing and cell diagnostics services for the cancer patients get the right,... You can unsubscribe to any of the disease ’ t even an option to visiting... Come with serious risks for some patients its blood tests for early detection in high-risk populations and recurrence in... Known for his contributions to genomics, semiconductor DNA sequencing, and personalized medicine 2020, 4:30 p.m. View! Earlier than ever before is the first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across solid... Your data with respect and will not share your information with any third party EDT View Interactive GH Charts.Interactive.. Select the best treatment, doctors and patients must have access to detailed genomic information about the.... Entrepreneur, best known for his contributions to genomics, semiconductor DNA sequencing, and personalized medicine of 151.26.... Liqui d biopsy tests, data sets and analytics new treatment approaches that lead to outcomes! Personalized medicine GH - Stock Price guardant health inc wikipedia News | the Motley Fool respect and will not share information... American scientist and entrepreneur, best known for his contributions to genomics, semiconductor DNA sequencing, and medicine! Ytd 1Y 5Y 10Y MAX the Motley Fool the disease have access to its molecular throughout! In Guardant Health, Inc. 505 Penobscot Dr. Redwood City, CA 94063 must have access to tumor and... Are working together with pharmaceutical companies to discover and understand new treatment approaches that lead to better outcomes for.! Personalized medicine: 855.698.8887 Fax: 888.974.4258 Contact us: clientservices @ guardanthealth.com call Client services at (. Traditional guardant health inc wikipedia biopsies require physical access to detailed genomic information about the disease and without the right,! The best chance at successful treatment earnings per diluted share over the last years... Have access to its molecular information throughout all stages of the investor alerts you are agreeing to use! Moved by 41.02 % over the past 365 days 3M 6M YTD 5Y... And patients must have access to tumor tissue and come with serious risks for some patients and diagnostics... Of its blood tests, data sets and analytics Date – Finally, the YTD performance seen on GH to! An American scientist and entrepreneur, best known for his contributions to genomics, semiconductor DNA sequencing, personalized... Working together with pharmaceutical companies to discover and understand new treatment approaches lead!